Filter
Exclude
Time range
-
Near
César Corchado retweeted
En VAA, la biopsia renal sigue aportando mucho más que Dx: 🔺Clasificación de Berden/EUVAS➡️ estratifica por patrón glomerular. 🔺RRS de Brix➡️ añade eGFR e IFTA, mejorando la predicción de evolución. 🔺 Mayo Clinic Chronicity Score (MCCS)➡️ evalúa cronicidad. #Jornadanefroreuma
9
16
546
Stay tuned for more updates - ESR in collaboration with EUVAS! Save the Date! 5 September 2026 Dubai #rheumatology #esr #euvas #uae #esr2026
13
The long-term survival of patients with #ANCA-associated #vasculitis (AAV) as well as potential prognostic factors were evaluated in a large long-term follow-up study that included 848 patients with newly diagnosed AAV from seven major European Vasculitis Society (EUVAS) randomized controlled trials. 𝗦𝘁𝘂𝗱𝘆 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻: ◦ 478 patients (56%) had granulomatosis with polyangiitis ◦ 370 patients (44%) had microscopic polyangiitis ◦ Mean age at diagnosis: 58 ± 14 years ◦ Median follow-up: 8 years (IQR 2.9–13.6 years) 𝗞𝗲𝘆 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀: ◦ 305 deaths occurred. ◦ Median survival: 17.8 years. ◦ Excess mortality vs. general population: 14.2% at 5 years, 19.9% at 10 years, 28.8% at 15 years, and 36.3% at 20 years. ◦ Main causes of death: Infections (26%), cardiovascular disease (14%), malignancies (13%). 𝗣𝗿𝗼𝗴𝗻𝗼𝘀𝘁𝗶𝗰 𝗙𝗮𝗰𝘁𝗼𝗿𝘀 (𝗶𝗻𝗰𝗿𝗲𝗮𝘀𝗲𝗱 𝗺𝗼𝗿𝘁𝗮𝗹𝗶𝘁𝘆 𝗿𝗶𝘀𝗸): • Older age • Male sex • Low eGFR (poor kidney function) • Low platelet count These findings indicate that despite improved treatments, AAV patients still have significantly higher long-term mortality, mainly due to infections and organ damage. Older males with renal impairment are at highest risk. *Sánchez Álamo B, Moi L, Bajema I, et al. Long-term outcomes and prognostic factors for survival of patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2023;38(7):1655-1665. 🔗doi.org/10.1093/ndt/gfac320
4
9
324
Replying to @MacedoDaniel_
*EUVAs = Estados Unidos e Vassalos das Américas
5
451
Replying to @AntjeHermenau
Eigentlich ja, aber, die "Zeugen EUvas", lesen zwischen den Zeilen!
1
2
199
Join us for our first #EUVAS BANFF-like #ANCA GN Symposium to discuss scoring and classification systems for clinical practice and research On September 29 at the beautiful Playfair Library in Edinburgh We have a few places left - sign up here: vasculitis.org/

ANCA GN Working Group Meeting More info for EUVAS Florence Working Group - Symposium on ANCA GN Classification-Scoring Systems, click link 👉vasculitis.org/ Register: 👇app.donorfy.com/form/ZU81NH9… @BrixSilke & Ingeborg Bajema #renalpath #vasculitis
1
8
18
2,799
ANCA GN Working Group Meeting More info for EUVAS Florence Working Group - Symposium on ANCA GN Classification-Scoring Systems, click link 👉vasculitis.org/ Register: 👇app.donorfy.com/form/ZU81NH9… @BrixSilke & Ingeborg Bajema #renalpath #vasculitis
15
36
5,349
Just look around and you’ll see that it’s true, not only the US but the EUvas well. (EU is vassal for Israel and US)
3
165
28 May 2025
The 6th EUVAS course was great both scientifically and socially! I was happy to share our experience in monogenic vasculitides
1
7
247
Vasculitis team @nfrgermanstrias with @veronicacoll & @paulaap30 . As always, the EUVAS VASCULITIS course surprises with high-level and very current talks. #Trieste
1
2
6
356
Wrapping up the 6th EUVAS Vasculitis Course in Trieste 🇮🇹 Great talks, great people, great learning. Thanks to all organisers, speakers & attendees! Many hanks to Professors Giacomo Emmi and Augusto Vaglio, for making this event such a success.
2
9
1,028
EUVAS 2025
9
988
I attended the #EUVAS #vasculitis course for the first time! 🌟 
It was a fantastic experience—listening to state-of-the-art updates from the stars of vasculitis and spending three days with so many dedicated professionals from various specialties was truly inspiring. 🎓
2
15
615